tiprankstipranks
Trending News
More News >
Grand Brilliance Group Holdings Limited (HK:8372)
:8372
Hong Kong Market

Grand Brilliance Group Holdings Limited (8372) AI Stock Analysis

Compare
1 Followers

Top Page

HK:8372

Grand Brilliance Group Holdings Limited

(8372)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 5.2)
Rating:68Neutral
Price Target:
HK$0.14
▲(15.00% Upside)
Action:DowngradedDate:12/09/25
The stock is supported by strong financial performance and a solid valuation, with a reasonable P/E ratio and dividend yield. However, technical indicators suggest caution due to overbought conditions. The lack of earnings call and corporate events data limits further insights.
Positive Factors
Revenue Growth Momentum
Sustained top-line growth demonstrates enduring demand for the company's lighting products and success in its distribution channels. Reliable revenue expansion supports reinvestment in product development, incremental capacity, and international expansion, strengthening long-term competitive position.
Conservative Balance Sheet
Very low leverage and a healthy equity base provide financial flexibility to absorb shocks, fund growth organically, or pursue strategic partnerships. Improved ROE shows capital is being used more effectively, reducing refinancing and solvency risks over a multi-month horizon.
Stable Profitability Margins
Improving net margin and stable operating margins indicate persistent cost management and pricing discipline. Consistent margins support sustainable cash generation and the ability to cover operating needs, fund modest capex, and maintain strategic investments over the medium term.
Negative Factors
Weak Cash Conversion
A large drop in free cash flow growth and very low operating cash conversion signal difficulty turning accounting profit into usable cash. This constrains funding for capex, working capital and dividends, increases reliance on external financing, and raises execution risk over coming months.
Margin Pressure on Gross Profit
A falling gross margin points to rising input costs or pricing pressure from competitors. If the trend persists, it can erode operating leverage and force margin trade-offs between volume and profitability, challenging sustainable earnings growth without structural cost or product premium improvements.
Concentrated Business Scope and Small Scale
Heavy reliance on core lighting products and a small organizational scale limit diversification, bargaining power with suppliers and retailers, and R&D bandwidth. This concentration raises vulnerability to sector-specific demand swings and competitive shocks over the medium term.

Grand Brilliance Group Holdings Limited (8372) vs. iShares MSCI Hong Kong ETF (EWH)

Grand Brilliance Group Holdings Limited Business Overview & Revenue Model

Company DescriptionGrand Brilliance Group Holdings Limited, an investment holding company, engages in supplying of medical devices in Hong Kong. It offers medical consumables; medical instruments; and medical equipment, as well as develops healthcare products. The company also provides medical device solutions, such as market trend analysis, sourcing of medical devices, after-sale services, technical support and training services, medical devices leasing services, and quality assurance services; and maintenance services, as well as holds trademarks. It sells its products to various private and public hospitals, private clinics, non-profit organizations, universities, and individual end-users. The company was founded in 1997 and is based in Tsuen Wan, Hong Kong. Grand Brilliance Group Holdings Limited is a subsidiary of B&A Success Limited.
How the Company Makes MoneyGrand Brilliance Group Holdings Limited generates revenue primarily through the sale of its lighting products, which include LED lights, fixtures, and other related accessories. The company has established a diversified revenue model that encompasses both direct sales to consumers and partnerships with distributors and retailers. Key revenue streams include domestic sales in Hong Kong, as well as international exports to various markets. The company may also engage in strategic partnerships with other firms to expand its product offerings or enhance distribution capabilities, thereby increasing its market reach and sales volume. Additionally, Grand Brilliance may benefit from economies of scale in manufacturing and supply chain efficiencies, contributing to its overall profitability.

Grand Brilliance Group Holdings Limited Financial Statement Overview

Summary
Grand Brilliance Group Holdings Limited demonstrates strong revenue growth and profitability, supported by a robust balance sheet with low leverage. However, the significant decline in free cash flow growth and low operating cash flow coverage ratio highlight potential cash flow management challenges.
Income Statement
75
Positive
Grand Brilliance Group Holdings Limited has shown a consistent revenue growth rate, with a 14.78% increase in the latest year. The gross profit margin has slightly decreased over the years, but the net profit margin has improved to 10.02%. The EBIT and EBITDA margins have remained stable, indicating efficient cost management. However, the decline in gross profit margin from previous years suggests potential pressure on cost control.
Balance Sheet
80
Positive
The company maintains a strong balance sheet with a low debt-to-equity ratio of 0.035, indicating low leverage and financial stability. The return on equity has improved to 8.54%, reflecting effective use of equity to generate profits. The equity ratio is healthy, suggesting a strong capital structure. Overall, the balance sheet reflects financial stability and prudent management of liabilities.
Cash Flow
60
Neutral
The cash flow statement shows a significant decline in free cash flow growth, down by 87.37% in the latest year, which is a concern. The operating cash flow to net income ratio is low at 0.072, indicating potential challenges in converting income into cash. However, the free cash flow to net income ratio remains strong at 0.87, suggesting that the company can still generate cash relative to its net income.
BreakdownTTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income Statement
Total Revenue105.25M94.45M81.90M76.70M71.98M70.24M
Gross Profit45.52M45.72M41.94M39.51M36.35M33.62M
EBITDA10.41M13.95M13.20M14.09M9.87M12.91M
Net Income10.07M9.46M7.86M7.56M4.05M7.86M
Balance Sheet
Total Assets137.53M132.19M114.50M115.25M110.32M112.01M
Cash, Cash Equivalents and Short-Term Investments53.86M60.96M60.47M61.86M55.74M70.26M
Total Debt3.06M3.91M1.43M4.45M4.48M4.87M
Total Liabilities24.20M20.75M11.22M16.58M16.82M18.96M
Stockholders Equity112.83M110.79M103.33M98.67M93.51M93.05M
Cash Flow
Free Cash Flow-3.77M1.17M4.91M12.60M-4.12M5.62M
Operating Cash Flow-3.58M1.35M6.72M12.66M-3.33M6.01M
Investing Cash Flow3.67M3.77M-395.00K-510.00K-3.96M-82.00K
Financing Cash Flow-4.93M-4.87M-7.42M-6.40M-7.58M-6.36M

Grand Brilliance Group Holdings Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.12
Price Trends
50DMA
0.13
Negative
100DMA
0.12
Positive
200DMA
0.12
Positive
Market Momentum
MACD
>-0.01
Positive
RSI
43.04
Neutral
STOCH
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8372, the sentiment is Neutral. The current price of 0.12 is below the 20-day moving average (MA) of 0.14, below the 50-day MA of 0.13, and above the 200-day MA of 0.12, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 43.04 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:8372.

Grand Brilliance Group Holdings Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
HK$104.00M5.399.25%1.89%27.91%18.87%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
50
Neutral
HK$117.65M-18.49-11.91%-4.50%75.98%
42
Neutral
HK$832.28M-5.63-465.55%-17.39%-45.76%
40
Underperform
HK$173.25M-0.48-20.78%6.78%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8372
Grand Brilliance Group Holdings Limited
0.13
0.03
32.65%
HK:0673
China Health Group
0.60
0.47
361.54%
HK:0718
Tai United Holdings
0.03
<0.01
17.86%
HK:0401
Wanjia Group Holdings Ltd.
0.11
0.03
45.83%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 09, 2025